Knights of the Nano Table

Among the United Kingdom's many traditions is the Queen's New Year' Honors List, a list of politicians, actors, writers and others awarded with knighthoods for distinguished services in fields ranging from charitable work to business to acting. Among this years honorees are Professors Andre Geim and Konstantin Novoselov, both of the University of Manchester.

As noted here in October 2010, Professors Geim and Novoselov were awarded the Nobel Prize in Physics for their discovery of graphene.

The two new knights join Sir Mark Edward Welland, head of theUniversity of Cambridge's Nanoscience Centre, in being honored for their contributions to the fields of nanotechnology and nanoparticle research. Sir Mark's knighthood was discussed here inJune 2011.

According to a press release on the University of Manchester's site, Professor Geim seemed to be taking his knighthood in stride:

Professor Geim said: “In my life, I have got used to being called four-letter names. Going down to three is a completely new experience which I will hopefully enjoy.”

Rule Britannia.

International Center for Technology Assessment et al v. Hamburg

On December 21, 2011, the International Center for Technology Assessment (ICTA), along with fellow plaintiffs Friends of the Earth (FOE), the Center for Environmental Health, Food and Water Watch, the Institute for Agriculture and Trade Policy, and the Action Group on Erosion, Technology and Concentration filed a complaint in the US District Court for the District of Norther California against Margaret A. Hamburg, Commissioner of the US Food and Drug Administration (FDA), requesting that "this Court enter an Order:

 

(1) Declaring that the Defendants have violated the Administrative Procedure Act by failing to respond to the 2006 Petition within a reasonable time;

(2) Declaring that the Defendants continue to be in violation of the Administrative Procedure Act by failing to respond to the 2006 Petition;

(3) Ordering Defendants to respond to the 2006 Petition as soon as reasonably practicable"

In May of 2006, ICTA filed a "Petition Requesting FDA Amend Its Regulations for Products Composed of Engineered Nanoparticles Generally and Sunscreen Drug Products Composed of Engineered Nanoparticles Specifically". The petition requested "that the Commissioner undertake the following actions with regards to all nanomaterial products:

1) Amend FDA regulations to include nanotechnology definitions necessary to properly regulate nanomaterial products . . . .

2) Issue a formal advisory opinion explaining FDA's position regarding engineered nanoparticles in products regulated by FDA.

3) Enact new regulations directed at FDA oversight of nanomaterial products establishing and requiring . . .that: nanoparticles be treated as new substances; nanomaterials be subjected to nano-spefic paradigms of health and safety testing; and that nanomaterial products be labeled to delineate all nanoparticle ingredients

4) Any currently existing or future regulatory FDA programs for nanomaterial products must comply with the requirements of the National Environmental Policy Act (NEPA) including . . . that FDA conduct a Programmatic Environmental Impact Statement (PEIS) reviewing the impacts of nanomaterial products on human health and the environment.

Petitioners request that the Commissioner undertake the following actions with regard to nanomaterial sunscreen drug products:

5) Reopen the Administrative Record of the Final Over the Counter (OTC) Sunscreen Drug Product Monograph for the purpose of considering and analyzing information on engineered nanoparticles of zinc oxide and titanium dioxide currently used in sunscreens.

6) Amend the OTC Sunscreen Drug Monograph to address engineered nanoparticles, instructing that sunscreen products containing engineered nanoparticles are not covered under the Mongraph and instead are "new drugs" for which manufacturers must complete a New Drug Application. . . .

7) Declare all currently available sunscreen drug products containing engineered nanoparticles of zinx oxide and titanium dioxide as an imminent hazard to public health and order entities using the nanoparticles in sunscreens regulated by FDA to cease manufacture until FDA's Sunscreen Drug Monograph is finalized and FDA nanotechnology regulations are developed and implemented.

8) Request a recall from manufacturers of all pulically available sunscreen drug products containing engineered nanoparticles of titatium dioxide and/or zinc oxide until the manufacturers . . .complete new drug applications, those applications are approved by the agency, and the manufactureres otherwise comply with FDA's relevant nanomaterial product testing regulations.

FDA held open meetings and established docket FDA -2006-P-0213 (two versions of this docket exist, on Regulations.gov and on the FDA's site). Comments were filed by various stakeholders between 2006 and 2009. Many of these comments, such as those submitted by Purest Colloids Inc and the Cosmetic, Toiletry and Fragrance Association (CFTA) severly criticized the ITCA's petition and urged the FDA not to take the actions requested in the petition.

In an interim response dated Nov. 9, 2006, Randall W. Lutter, then the FDA's Associate Commissioner for Policy and Planning noted that the

. . .FDA has been unable to reach a decision on your petition because it raises complex issues requiring extensive review and analysis by agency officials. . . . We will respond to your petition as soon as we have reached a decision on your requests.

Almost six years later, FDA is still in the process of formulating regulations and policy affecting nanotechnology and nanoindustry.

The parties in the case have been referred by the US Distirct Court to Alternative Dispute Resolution. We will continue to monitor the case and update as warranted.

UPDATE:

The parties in International Center for Technology Assessment et al v Hamburg, in a stipulation filed with the court on January 13, 2012, agreed  to grant the EPA " an extension of time to April 23, 2012 to answer, move, or otherwise respond to the complaint". EPA requested the extension "because defendent is working in good faith to respond to the citizen petition . . .on or before April 23, 2012."

As before, we'll keep monitoring and updating as warranted.

Nanotech brings new investment to upstate New York

In the midst of "The Great Recession" the last month's announcement  by Governor Andrew Cuomo of New York that a consortium composed of IBM, Intel, Samsung Electronics US, Taiwan Semiconductor Manufacturing Company (TSMC), and Globalfoundries, will be investing $4.4 billion over five years to create R&D facilities in Albany, Utica, and other cities in upstate New York, for the purpose of applying nanotechnology to manufacture smaller and more efficent computer chips (nanochips).

This investment also means that over 2500 existing jobs will remain in New York and 2500 new jobs will be created directly by the consortium, slong with an estimated 1900 construction jobs that will be created to renovate existing and to construct new facilities.

To help support the R&D work, the state government of New York will direct $400 million, also over a five year period, to SUNYCollege of Nanoscale Science and Engineering in Albany. In addition, it is expected that further investment and job creation will result from the purchase of goods and services by the members of the consortium from local businesses.

Although the announcement was greeted with praise by the Business Council of New York State, it was greeted with more cautious optimism by the local newspaper and by local government officials.

If at first you don't succeed . . . .

Congress returns to Washington  from the August recess this week and among the bills that may come up for consideration between now and the end of the 1st session of the 112th Congress is H.R. 2359, the "Safe Cosmetics Act of 2011", introduced by Rep. Janice Schakowsky (D-IL-9th) on June 24, 2011 and subsequently referred to the House Committees on Energy and Commerce and Education and the Workforce.

As that noted philosopher, wordsmith, catcher and manager of the New York Yankees and the New York MetsLawrence "Yogi" Berra once expressed, "It's deja vu all over again."

H.R. 2359 is an only slightly changed version of H.R. 5786, the "Safe Cosmetics Act of 2010", introduced by Rep. Schakowsky on July 20, 2010 and referred to the same House Committees (the House Committee on Education and the Workforce was then known as the House Committee on Education and Labor) and discussed here on July 26, 2010.

The language affecting nanoparticles in cosmetics, section 613 in H.R. 2359, is the same as it was in section 618 of the previous bill:

SEC. 613. INGREDIENTS LABELS ON COSMETICS

 

    `(d) Labeling of Nanomaterials in Cosmetics- The Secretary may require that--

 

      `(1) minerals and other particulate ingredients be labeled as `nano-scale' on a cosmetic ingredient label or list if not less than 1 percent of the ingredient particles in the cosmetic are 100 nanometers or smaller in not less than 1 dimension; and

 

      `(2) other ingredients in a cosmetic be designated with scale-specific information on a cosmetic ingredient label or list if such ingredients possess scale-specific hazard properties.

Similarly, the language of section 614 in H.R. 5786 is now part of section 615 in H.R. 2359:

SEC. 615. COSMETIC AND INGREDIENT SAFETY INFORMATION.

      `(2) CONSIDERATION OF NANOMATERIALS- The Secretary shall--

 

        `(A) monitor developments in the scientific understanding from any adverse health effects related to the use of nanotechnology in the formulation of cosmetic (including progress in the standardization of testing methods and specific size definitions for nanomaterials); and

 

        `(B) consider scale specific hazard properties of ingredients when reviewing and evaluating the safety of cosmetics and ingredients under paragraph (1).

       

No hearings on H.R. 5786 were ever held, nor was it reported out of committee. No hearings are currently scheduled for H.R. 2359.

Danish EPA Releases Report on Environmental & Health Risks for Selected Nanoparticles

Denmark's Environmental Protection Agency (DEPA)  recently released "Survey on basic knowledge about exposure and potential environmental and health risks for selected nanoparticles". The survey was written by Sonja Hagen Mikkelsen, Erik Hansen and Trine Boe Christensen of COWI A/S, Anders Baun and Steffen Foss Hansen of DTU Environment and Mona-Lise Binderup of DTU Food, all working under contract with DEPA.

Noting that "There is no single source of information that provides an overview of nanomaterials and products in Denmark or in the EU for that matter",

DEPA has therefore initiated this project to provide an overview of the existing knowledge about seven of the most common nanomaterials, their environmental and health properties, the use of those nanomaterials and the possibility of exposure of humans and the environment.

The seven nanomaterials selected as the focus of the survey are

1 - Titanium dioxide

2 - Cerium dioxide

3- Fullerenes (aka carbon balls or 'buckeyballs")

4- Nanosilver

5- Zero-valent iron

6 - Silicium dioxide

7 - Nanoclay

These nanomaterials were selected based on

1- Application volums

2- Potential human exposure

3- Potential direct discharge into the environment

4 - Expected biological effect (human and/or environment), persistence or bioaccumultion

The authors of the survey developed "profiles" for the nanomaterials, focusing on " the general characteristics and manufacture of the nanomaterial, their current uses (mainly focused at consumer products) and hazard profiles (ecotoxicity and human toxicity) . . . . The profiles included sections discussing relevant exposures from consumer products and considerations regarding the related risk."

The first two chapters of the survey, "Introduction" and "Nanomaterials Survey" discuss the nature of the nanomaterials, their use in industries, general availability of products incorporating the nanomaterials and brief summaries of earlier studies. Chapters 3-9 focus on the individual nanomaterials selected for this survey, discussing the general characteristics of a specific nanomaterial, how it is manufactured, which consumer products available in Denmark, either via a website or a bricks and mortor shop, review of toxicity studies, possible scenarios where humans and the environment might be exposed to the nanomaterials, ranging from disposal of products containing nanomaterials in landfills to the use of nanomaterial ensconced cosmetics, such as sunscreens containing titanium dioxide, and brief discussions of "risk profiles" for the selected nanomaterials. Summary sheets are found at the end of the chapters.

Chapter 10, "Exposure and risk potential", raises a point that critics of this survey will note:

. . . the range of toxicological and ecotoxicological studies available is not sufficient to allow firm conclusions with regard to the toxicity of the nanoparticles compared to their bulk counterparts. . . (emphasis added)

As one might then expect, the authors of this survey come to the conclusion that, in order to answer the questions regarding nanomaterials and risk more information and research is needed.

The NANO Act

Prior to Congress adjournment for the traditional August recess, Rep. Mike Honda (CA-15th-D) introduced H.R. 2749, "The Nanotechnology Advancement and New Opportunities (NANO) Act", described by Rep. Honda as ". . .a comprehensive bill to promote the development and responsible stewardship of nanotechnology in the United States . . . .[drawing] upon th work of the Bluee Ribbon Task Force on Nanotechnology . . . " convened by Rep. Honda and then California State Controller Steve Westly in 2004. H.R.2749 includes some of the recommendations offered by the Task Force in their report, "Thinking Big About Thinking Small: An Action Agenda for California", released in 2005.

According to Rep. Honda's remarks of August 1,2011

. . . the bill addresses concerns that have been raised about whether the Federal Government is doing enough to address potential health and safety risks associated with nanotechnology. The NANO Act requires the development of a nanotechnology research strategy that establishes research priorities for the Federal Government and industry that will ensure the development and responsible stewardship of nanotechnology. This strategy will help to resolve the uncertainty that is one of the major obstacles to the commercialization of nanotechnology--uncertainty about what the risks might be and uncertainty about how the Federal Government might regulate nanotechnology in the future.

  • The NANO Act also includes a number of provisions to create partnerships, raise awareness, and implement strategic policies to resolve obstacles and promote nanotechnology. It will: create a public-private investment partnership to address the nanotechnology commercialization gap; establish a tax credit for investment in nanotechnology firms; authorize a grant program to support the establishment and development of nanotechnology incubators; establish a Nanoscale Science and Engineering Center for ``nano-CAD'' tools; establish grant programs for nanotechnology research to address specific challenges in the areas of energy, environment, homeland security, and health; establish a tax credit for nanotechnology education and training program expenses; establish a grant program to support the development of curriculum materials for interdisciplinary nanotechnology courses at higher education institutions; direct NSF to establish a program to encourage manufacturing companies to enter into partnerships with occupational training centers for the development of training to support nanotechnology manufacturing; and call for the development of a strategy for increasing interaction on nanotechnology interests between DOE national labs and the informal science education community.

Title I, "Investment in Nanotechnology Industry", directs the Secretary of Commerce to "establish the Nanomanufacturing Investment Partnership (NIP) . . .with private sector investments", contingent on the private sector raising $100,000,000 within two years of the NANO act being passed and signed into law. Although it's unstated in the text of the bill, should the private sector fail to raise the $100,000,000 by the end of the two years, the NIP would not be established and Title I rendered moot.

The NIP's purpose would be to

provide funding for precommercial nanomanufacturing research and development projects, . . .  through funding mechanisms described in subsection (c) in a manner so as to advance the commercialization of nanomanufacturing technologies to address critical scientific and engineering needs of national importance, especially with respect to projects that would not be adequately funded or pursued by the private sector or pursuant to the 21st Century Nanotechnology Research and Development Act or other law, and to increase the commercial application of federally supported research results. . . .at least 85 percent of the funding provided by the Nanomanufacturing Investment Partnership under this section shall be provided to startup companies.

The funding would be in the form of "direct investments . . .contracts, loans, or loan guarantees, unsecured subordinated debt, or any other mechanism designed to advance nanomanufacturing technologies". In turn, the start-up enterprises that received investments from NIP would "return to the Nanotechnology Investment Partnership. . .. fair and reasonable amounts resulting from the commercialization of technologies developed with funding provided by the Nanotechnology Investment Partnership."

An Advisory Board consisting of

        (A) representatives of each investor providing more than $10,000,000 to the Nanomanufacturing Investment Partnership, whose votes shall--

 

          (i) be distributed proportional to the size of their investment in the Nanomanufacturing Investment Partnership; and

 

          (ii) collectively amount to 40 percent of the votes on the Advisory Board; and

 

        (B) independent experts on nanomanufacturing and finance appointed by the President from among representatives of government, industry, and academia, whose votes shall collectively amount to 60 percent of the votes on the Advisory Board.

 

would be established to assist the Secretary of Commerce in making awards.

Section 102 of the NANO Act would create a tax credit to encourage the purchase of "qualified technology developer stock", defined as  meaning ". . . any common stock in a C Corporation or any membership unit in a state registered limited liability company  . . . "

The act defines a "qualified technology developer as ". . .  any entity

        `(A) which is a C corporation or limited liability company organized under the laws of any State or of the United States,

 

        `(B) which is a small business concern (as defined in section 3(a) of the Small Business Act), and

 

        `(C) with respect to which a certification under subsection (d) is in effect. . . .

 

 

    `(d) Certification-

 

      `(1) IN GENERAL- The Secretary, in consultation with the National Nanotechnology Coordination Office, shall certify an entity under this subsection if such entity demonstrates by the submission of such information as required by the Secretary that not less than 51 percent of its activities relate to the development, production, and sale of products using nanotechnology.

 

      `(2) REVOCATION- The Secretary shall revoke the certification of any entity which is certified under paragraph (1) if the Secretary determines that--

 

        `(A) the proceeds from any qualified nanotechnology developer stock issued by such entity are used during the 5-year period following such issue for a purpose other than the development, production, or sale of products using nanotechnology, or

 

        `(B) such entity no longer meets the requirements of paragraph (1).

       

Section 103 would direct the Secretary of Commerce to award competitive grants for the acquisition/renovation of space to serve as nanomanufacturing "incubators", defined as meaning

an entity affiliated with or housed in a degree-granting institution that provides space and coordinated and specialized services to entrepreneurial businesses that work in the field of nanotechnology commercialization and that meets selected criteria during the businesses' startup phase, including providing services such as shared office space and services, access to equipment, access to telecommunications and technology services, flexible leases, specialized management assistance, access to financing, and other coordinated business or technical support services.

Other grants would be awarded to develop "curricula related to nanotechnology;

 

            (II) providing services for commercialization, including preparing providing services to appropriate businesses including corporate charters, partnership agreements, and basic contracts, assistance with patents, trademarks, and copyrights, and technology acquisition services; or

 

            (III) providing programming for entrepreneurs working in nanotechnology housed in an incubator;

    Other grants would be awarded "for feasibility studies for determining the need for or siting of incubators, and for "research regarding best practices for incubator programs. . . ."

    The Secretary of Commerce

    shall establish a Nanotechnology Startup Advisory Council composed of industry leaders, business and marketing professionals, venture capitalists, attorneys, and nanotechnology researchers.

     

        (2) PURPOSE- The purpose of the Nanotechnology Startup Advisory Council is to ensure that emerging nanotechnology companies create a sound foundation for new business.

       

    Title II, "Research and Development Directions", contains provisions directing the Secretaries of Energy, Homeland Security, Health and Human Services, and the Administrator of the Environmental Protection Agency (EPA), to establish grant programs for nanotechnology research "to address the need for "clean, cheap, renewable energy","sensors and other materials related to Homeland Security needs", "Health related applications of nanotechnology", and "technologies for the remediation of pollution and other environmental protection technologies".

    Title III, "Environmental Nanotechnology Applications", requires the Director of the National Nanotechnology Coordination Office, not later tahn one year following enactment of the NANO Act to

    . . . after consultation with appropriate Federal agencies and industry, transmit to the Congress a report containing a nanotechnology research strategy that establishes priorities for the Federal Government and industry that will ensure the development and responsible stewardship of nanotechnology. The report shall include recommendations regarding the funding levels the Director anticipates the agencies charged with implementing this research strategy will require

    Title IV, "Education" would create a tax credit

    for the taxable year an amount equal to 50 percent of nanotechnology education and training program expenses paid or incurred by the taxpayer for the benefit of--

     

          `(A) in the case of a taxpayer engaged in a trade or business, an employee of the taxpayer, or

     

          `(B) in the case of a taxpayer who is an individual not so engaged, such individual. . . .

            `(c) Nanotechnology Education and Training Program Expenses- For purposes of this section--

           

              `(1) IN GENERAL- The term `nanotechnology education and training program expenses' means expenses paid or incurred by reason of the participation of the taxpayer (or any employee of the taxpayer) in any nanotechnology education and training program. Such expenses shall include expenses paid in connection with--

           

                `(A) course work,

           

                `(B) certification testing,

           

                `(C) programs carried out under the Act of August 16, 1937 (50 Stat. 664, chapter 663; 29 U.S.C. 50 et seq.) which are registered by the Department of Labor, and

           

                `(D) other expenses that are essential to assessing skill acquisition.

           

              `(2) NANOTECHNOLOGY EDUCATION AND TRAINING PROGRAM- The term `nanotechnology education and training program' means a training program in nanotechnology workplace disciplines or other skill sets which is provided in the United States by an accredited college, university, private career school, postsecondary educational institution, a commercial nanotechnology provider, or an employer-owned nanotechnology training organization. . . .

              SEC. 402. ELIGIBLE EDUCATIONAL INSTITUTION.

               

                (a) In General- Section 25A(f)(2) of the Internal Revenue Code of 1986 (relating to eligible educational institution) is amended to read as follows:

               

                  `(2) ELIGIBLE EDUCATIONAL INSTITUTION- The term `eligible educational institution' means--

               

                    `(A) an institution--

               

                      `(i) which is described in section 101(b) or 102(a) of the Higher Education Act of 1965, and

               

                      `(ii) which is eligible to participate in a program under title IV of such Act, or

               

                    `(B) a commercial nanotechnology training provider (as defined in section 30E(c)(3)).'.

    The National Science Foundation (NSF) would be directed to establish a competitive grant program to assist with the cost of developing "curriculum materials for interdisciplinary nanotechnology courses at institutions of higher learning". NSF would also be required, through the Advanced Technological Education Program, to "establish a program to encourage manufacturing companies to enter into partnerships with occupational training centers for the development of training to support nanotechnology manufacturing."

    Title V, "Public Outreach", directs the Secretary of Energy

      Not later than 6 months after the date of enactment of this Act, the Secretary of Energy shall transmit to the Congress a report containing a strategy for increasing interaction on nanotechnology issues between scientists and engineers at the Department of Energy's National Laboratories and in the informal science education community, to enable researchers to use their expertise to assist in the development of appropriate nanotechnology exhibitions for school age children and the general public.

    H.R. 2745 has been referred to the House Committees on Science, Space and Technology, Energy and Commerce, Homeland Security, and Ways and Means, "for consideration of such provisions as fall within the jurisdiction of the committee concerned."

    Any consideration of H.R. 2745 will not occur until the House  returns from recess on September 6.

    Tags:

    EPA Extends comment period

    Wednesday's Federal Register carried a notice from the Environmental Protection Agency (EPA) extending the comment period for proposed methods of collecting information regarding the use of nanoscale materials in pesticides published in the Federal Register of June 17, 2011. The original deadline for submitting comments was July 18, 2011. The deadline for submission has been extended to august 17, 2011.

    The 30 day extension was requested by four commenters - Croplife America, a trade group repsenting " the developers, manufacturers, formulators and distributors of plant science solutions for agriculture and pest management in the United States", the American Chemical Council, the Chemical Producers and Distributors Association, a trade group "representing the interests of generic pesticide registrants, with a membership that includes manufacturers, formulators, and distributors of pesticide products", and theInternational Center for Technology Assessment, "a non-profit, bi-partisan organization committed to providing the public with full assessments and analyses of technological impacts on society". The comments may beviewed on Regulations.gov.

    Information on submitting comments is available from either the original notice or the notice published on Wednesday.

    Adjusting the picture: LCDs and Quantum Dots

    An article, "Dotting the Eyes" published in the June 16, 2011 issue of The Economist, noted something that many of us who spend a good part of their day looking into Liquid Crystal Display (LCD) screens, such as the monitor for the pc that I'm writing this on or the one you're reading it on, have long known - the color range is very limited. Jason Hartlove, President and CEO of California based Nanosys, believes his company may have found a way to expand the color range available to LCDs, using plastic sheets coated with quantum dots that his company manufactures. which - according to the Nanosys website - enables

     LCDs to display about 50% more color than they can today. This means richer, more viscerally alive reds, a deeper palette of greens (the color the human eye sees more intensely than any other color) and vivid blues. Browsing through photos on a tablet is now more like holding a stack of high quality, professional prints. Watching a movie on a big screen in the living room is more akin to attending a private screening at a Hollywood studio.

    Other companies, such as Samsung Electronics and QD Vision of Massachusetts, have also begun to design, test and market their own products with the same goal as Nanosys - using quantum dots to improve the picture quality and color range of LCDs, efficently and at low cost.

    Nanotechnology Law -- New 2011 Edition

    The new 2011 edition of Nanotechnology Law published by West/Thomson/Reuters is now out.  I update the book every year and the new edition has lots of new stuff.  They make excellent Christmas and Birthday gifts, and are a general cure for insomnia.  All proceeds go to my underprivileged daughters' college fund.  Everyone should have one (or two). 

    Senate Hearing on The National Nanotechnology Investment: Manufacturing, Commercialization and Job Creation"

    The Senate Committee on Commerce, Science and Transportation Subcommittee on Science and Space will be holding a hearing at 10AM on Thursday July 14, "The National Nanotechnology Investment: Manufacturing, Commercialization and Job Creation",

    As the Commerce Committee considers a reauthorization of the National Nanotechnology Initiative, the hearing will examine the potential of nanotechnology, federal initiatives to coordinate research investments, barriers to commercialization, possible environmental and health risks, and steps Congress can take to improve the return on federal nanotechnology investments.

    Appearing before the Subcommittee are the following witnesses:

      • Dr. Chad A. Mirkin
        Director, International Institute for Nanotechnology, Northwestern University
        Member of the President’s Council of Advisors on Science and Technology

      • Dr. Charles (Chuck) H. Romine
        Acting Associate Director, Laboratory Programs, and Principal Deputy, Office of the Director
        National Institute of Standards and Technology

      • Dr. Diandra Leslie-Pelecky
        Director, West Virginia Nano Initiative
        Professor of Physics, West Virginia University

      • Dr. Thomas O'Neal
        Associate Vice President for Research and Commercialization, University of Central Florida
        Executive Director, University of Central Florida Business Incubation Program

      • Dr. George L. McLendon
        Howard R. Hughes Provost and Professor of Chemistry
        Rice University

       

    The hearing will also be webcast on the Committee's website. The witnesses prepared statements will be posted to the Subcommittee's site the day of the hearing.

    New Nanoscale Carbon Website -- CNT Report

    Readers may be interested in learning about a new subscription website devoted to nanoscale carbon -- CNT Report

    CNT Report is dedicated to bringing its readers the most recent news concerning important issues affecting nanoscale carbon research, development, and commercialization.  CNT Report closely covers all forms of nanoscale carbon in development on the global stage, including CNTs, graphene, fullerenes, specialty fibers, and all else in-between.  CNT Report's primary focus is on new scientific research developments, practical applications, finance, legal and regulatory issues, and general commercialization.   CNT Report publishes news in several broad categories including: Business, Commercialization,  Finance & Deals, Insurance, Intellectual Property, International Laws & Regulations, Policy, Standards, States, Science, Applications, Current Research, and Environmental, Health and Safety.

    CNT Report also accepts press releases, research results, financial news, or any other news item related to nanoscale carbon which it then makes available to all of its subscribers.  CNT Report welcomes timely contributions from its readers and makes sure that their articles receive proper attribution and credit.

     

    FY 2012 National Defense Authorization Act: The Senate Version

    On June 17, 2011, the Senate Committee on Armed Services announced that S. 1253, the National Defense Authorization Act for FY 2012 had been passed unanimously and had been reported out of Committee and sent on to the Senate for debate.

    S. 1253 provided $200 million in funding for the "Rapid Innovation Program" established by PL 111-383, the 2011 National Defense Authorization Act.  $50 million of this is directed to the development of advanced materials, including nanomaterials, as described in S. Report 112-26

      2. Developing advanced materials: $50.0 million for increased investment in a broad range of materials technologies, both organic and inorganic, that can provide enhanced performance in extreme environments; enhanced strength and reduced weight for the spectrum of applications from aerospace to lighter soldier loads; enhanced survivability of ground, air, and naval systems; and tailored physical, optical, and electromagnetic properties for a wide variety of the challenging environments and unique properties demanded of military systems. Such materials could include advanced composites and metals, nanomaterials, and rare-earth alternatives. Investments could also address new techniques for manufacturing and processing these materials, including advancements in forming, joining, and machining. Whether increasing survivability or improving fuel efficiency for greater performance, advanced materials are a foundational enabling component of military systems across all services and all warfighting domains;

    S. Rept. 112-26 also contains the following language, which doesnot appear in S. 1253 as reported:

    Nanotechnology research

    The Department of Defense (DOD) is one of 25 federal agencies that are part of the National Nanotechnology Initiative (NNI) that was launched in 2001. The goals of the NNI are to: advance a world-class nanotechnology research and development (R&D) program; foster the transfer of new technologies into products for commercial and public benefit; develop and sustain educational resources, a skilled workforce, and the supporting infrastructure and tools to advance nanotechnology; and support responsible development of nanotechnology. As a participant in the NNI, DOD leverages its own and other federal investments, primarily in basic research, to discover and exploit unique properties of materials at the nanoscale to enable new applications enhancing future weapon systems capabilities.

    Given the broad applicability of nanotechnologies to important areas such as power and energy, electronics and sensors, and advanced materials and coatings, the committee seeks to ensure that the DOD is engaging with as broad a research community as possible to maximize its access to innovative ideas and products. Hence, the committee directs the Department to provide a briefing to the Committees on Armed Services of the Senate and the House of Representatives no later than 180 days after the enactment of this Act reviewing its sources of nanotechnology research and engineering for defense purposes. Furthermore, the briefing should address whether these sources are adequate to ensure that the Department has sufficient scientific and technical access across the spectrum

    S. 1253 now awaits debate in thge Senate, as does HR. 1540, the House version of the FY 2012 National Defense Authorization Act. A likely scenario for both bills would be for the Senate to call up HR 1540 and amend it by substituting the language of S. 1253 after the enacting clause, which would send the amended bill back to the House. If the House agrees to the amendment, the bill would be passed and sent to President Obama to be signed into law or vetoed. A more likely scenario would be for the House to disagree with the amendment, sending it to a Conference Committee , which would be tasked with producing a comprise version that both the Senate and the House could agree to pass.

    As with other legislation affecting nanotech, we'll monitor S. 1253's progress and provide updates.

    EPA Requests Public Comment on Obtaining Information Regarding Nanomaterials in Pesticides

    On June 17, 2011, the Environmental Protection Agency (EPA) published a notice in the Federal Register announcing that it was seeking "comment on several possible appraoches for obtaining information about what nanoscale materials are present in registered pesticide products. . .  . and its potential effects on humans or the environment. . . ."

    Under one approach to collecting this information, EPA would use the authority granted to it by the Federal Insecticide, Fungicide,and Rodenticide Act  (FIFRA) to require applicants to "provide any factual information of which [the applicant] is aware regarding unreasonable adverse effects of the pesticide on man and the environment". If EPA adopts this approach, it would require the inclusion of "such information with applications for registrations of pesticides or pesiticide products containing 'nanoscale materials'".

    Under a different section of FIFRA, EPA would gather information using Data Call-In notices.

    EPA is required to collect information regarding pesticides under section 3(a) of FIFRA. Using the information collected, EPA can then determine

    1) the validity of the products claims

    2) that labelling complies with FIFRA requirements

    3) that the pesticide or pesticide product will not cause unreasonably adverse harm to humans or the environment.

    EPA "believes that certain information concerning pesticide ingredients" - in this case, nanoscale materials, defined by EPA as (1) between 1 and 100 nanometers, (2) " exhibit unique and novel properties compared to larger particlesof the same material" and (3) has been manufactured or engineered at the nanoscale level to take advantage of those unique or novel properties - have not been routinely provided to EPA, complicating the agency's attempts to fulfill its legal obligations.

    In determining whether an ingredient meets this description, EPA
    may review particle size data and, among other things, the
    manufacturing process to determine whether it employs processes
    specifically to create or enhance the proportion of nanoscale materials
    in the product, as compared with other processes used to produce
    similar products. The Agency generally expects that these ingredients
    may comprise, but are not limited to, metal-based (e.g., silver) and
    carbon-based (e.g., carbon nanotubes) nanoscale materials. . . EPA would
    review information provided by a registrant or applicant concerning the
    composition of the pesticide product and to provide an Agency view on
    whether the product did (or did not) contain a nanoscale material for
    purposes of this policy.

     

    Noting that ". . . there is a growing body of scientiific evidence showing that differences can exist between nanoscale material[s] and their non-nanoscale counterpoint[s]. . . EPA sees the emergence of nanoscale materials as offering . . .potential benefits for society in many different fields, including pest control products". Among these potential benefits are :

    1) creation of more effective and efficient targeting of pesticide products

    2) use of smaller quantities of pesticide products, reducing the amount of pesticides circulating in the environment

    3) reducing the frequency of usage of these products.

    All of these benefits would lead to "improved human and environmental safety and could lower pest control costs. . .. EPA seeks to encourage innovative work in developing nanoscale materials to realize these benefits".

    But while EPA may be encouraging innovative work to realize those benefits, it is also aware that

    the small size . . . or the unique or enhanced properties of nanoscale materials may, under specific conditions, pose new or increased hazards to humans and the environment. . . . It is important to empasize that  . . any individual type of nanoscale material may
    not display all or even any of the characteristics observed and
    reported for other nanoscale materials. In other words, some nanoscale
    materials may have properties which, for purposes of assessing the risk
    of a pesticide, are essentially identical to larger sized materials (or
    particles) of the same substance. Furthermore, nanoscale materials may
    also have properties that make them less risky, or more beneficial in
    some other way, than larger sized materials (or particles) of the same
    substance. So, it appears increasingly likely that there are few, if
    any, universal ``nanoscale'' effects, and the distinctive effects seen
    at nanoscale are specific to the properties of each material type under
    specific exposure scenarios. Thus, EPA does not regard the fact that an
    ingredient meets our description of a nanoscale material as evidence
    that a pesticide containing the ingredient would cause unreasonable
    adverse effects on the environment and thus would no longer meet the
    statutory standards for registration. Rather, the presence of a
    nanoscale material in a pesticide is grounds for EPA to consider the
    possible need for data to characterize the potential of the ingredient
    to pose risks. However, the registration status of a product would not
    change merely as a result of providing information to EPA about the
    presence of a previously-unreported nanoscale material. If, based on a
    science based assessment of the risks of the specific pesticide
    ingredients involved, EPA were to determine that the pesticide no
    longer met the criteria for registration, or that some change was
    needed in the conditions of use, EPA would conduct a separate action to
    notify the manufacturer of that determination, consistent with current
    FIFRA regulations.
        Finally, scientifically speaking, there currently is no bright line
    with respect to a size below (or above) which nanoscale materials do
    (or do not) exhibit properties that might be of interest in assessing
    whether a pesticide product has the potential to cause unreasonable
    adverse effects on the environment. Therefore, the precise size range
    in nanometers addressed by the policies proposed in this document might
    be revised in the future as new information becomes available.

    EPA believes that any of the
    following types of information are relevant to assessing the potential
    of a pesticide to cause unreasonable adverse effects on the
    environment:
        Any information concerning what nanoscale materials are
    present in pesticides, whether as an active ingredient or as an inert
    ingredient;
        For any pesticide product that contains nanoscale
    material, whether active or inert, any existing information that
    characterizes the size and size distribution of the nanoscale material
    as measured in nanometers;
        For any pesticide product that contains nanoscale
    materials, whether active or inert, any existing information that
    describes the manufacturing process used to produce the nanoscale
    material in whatever size range it is produced;
        For any pesticide product that contains nanoscale
    materials, whether active or inert, and that also is or will be used
    for an end-use formulation that contain(s) a composite (e.g., the
    active ingredient is a matrix complex comprised of the nanoscale
    material(s) in combination with a carrier, such as silica or sulfur),
    any existing information that characterizes the size and size
    distribution of the composite; and
        For any pesticide product that contains nanoscale
    materials, whether active or inert, any existing information that shows
    adverse effects at any level of exposure to the nanoscale material on
    humans or nontarget species, and/or that shows the levels or nature
    (e.g. routes, frequency, or life stage) of potential human and environmental exposure.
    . . . . the foregoing is not intended to be an exclusive list.
    To the extent that a registrant has a pesticide product that contains a
    nanoscale material, and in addition has any other existing information
    not captured in the previous list that pertains to, concerns, or
    otherwise relates to the nanoscale material and has the potential to
    raise questions about the continued registration of a product or the
    appropriate terms and conditions of a product registration, EPA is also
    considering whether this too should be submitted to the Agency.
     

    The main purpose of this notice was to solicit comments regarding how EPA will collect information regarding nanoscale materials in pesticides or pesticide products. As stated above, EPA is considering two methods.

    The first is to require that information submitted by registerants of pesticides under 6(a)(2) of FIFRA include information about nanoscale materials.

    Noting that some stakeholders have objected to this method of collecting information as (1) potentially stigmatizing nanoscale materials as causing "adverse effects" on humans and/or the environment and (2) "overly burdensome", EPA notes that

    1) " It is . . .EPA's position that . . .filing an additional report . . .doesnot stigmatize pesticides and wouldnot stigmatize any nanomaterials in pesticides since filing such reports is quite common."

    2) . . . only registrants who know that their products contain nanoscale
    materials would be required to report to EPA. Further, they would be
    required to report only the information they know about. Section
    6(a)(2) does not require a registrant to generate new data or to seek
    out additional information. Further, registrants and applicants whose
    products do not contain nanoscale materials (or who do not know that
    their products contain nanoscale materials) would have no reporting
    obligation under FIFRA section 6(a)(2).

    Alternatively, EPA could gather the information it needs by using the authority granted to it under section 3(c)(2)(B) of FIFRA to issue Data-Call In Notices and to require the inclusion of this information "with any application for registration of a pesticide product that contains a nanoscale material". The use of DCIs would prove burdensome for both EPA and registrants, requiring the former to have to create new administrative procedures to monitor the intake and processing of reports, and for the latter, who would have to generate data about it's products that it didn't have

    Under either the 6(a)(2) or the 3(c)(2)(B) approach, DCIs targeted
    to individual pesticide products that contain specific nanoscale
    materials would likely be used in the future to collect more specific
    information or data about particular products. EPA would consider doing
    so on a case-by-case basis and would tailor any request for information
    accordingly.

     

    Some stakeholders have suggested that EPA simply propose a new regulation to require the disclosure of what nanoscale materials are present in a pesticide as part of the application for registration of a pesticide. EPA, while not considering proposing such a regulation at this time, is also seeking comment on that appraoch.

    EPA is also considering a change in policy in how it classifies applications for registration of pesticides with nanoscale materials

    . . . . EPA is thus proposing that it not make
    the requisite findings absent specific information on the nanoscale
    material included in a pesticide product when the application relies on
    a comparison to a currently registered pesticide product containing
    either a non-nanoscale version of the same ingredient or another
    nanoscale version of the ingredient that has different characteristics. 
    . . . .  EPA would initially classify any application for
    registration of a pesticide product containing an active or inert
    ingredient that is a nanoscale material as an application for a ``new''
    active or inert ingredient, even when another registered pesticide
    product contains a non-nanoscale form of the ingredient or a nanoscale
    form of the ingredient with different size dimensions or other
    properties. This initial presumption, however, could be rebutted on a
    case-by-case basis through the submission of, among other
    possibilities, bridging data or other information demonstrating to
    EPA's satisfaction that the nanoscale material's properties, which are
    relevant to assessing the potential risks to human health and the
    environment, are substantially similar to the properties of the
    already-registered non-nanoscale or already-registered nanoscale form
    of the material, or that the nanoscale material differs only in ways
    that do not significantly increase the risk of unreasonable adverse
    effects on the environment, and that approving the registration in the
    manner proposed would not significantly increase the risk of any
    unreasonable adverse effect on the environment.
        If an applicant could make this showing to EPA's satisfaction, then
    the application would be processed as a ``me-too'' application within
    the timeframes prescribed for such applications.

    EPA concludes the notice by presenting several questions for respondents to consider:

    EPA  specifically invites comments on the following issues:
        1. In view of the Agency's goal of identifying what nanoscale
    materials are in products so that EPA can determine whether it needs
    additional data to evaluate the products' safety under FIFRA, should
    EPA change the description of a ``nanoscale material''? For example,
    should the size range remain ``between approximately 1 and 100 nm in
    one dimension''? Are there other characteristics that EPA should
    consider, e.g., morphology, including shape and crystal structure;
    surface chemistry and reactivity; specific surface area, charge;
    solubility; conductive, magnetic, and optical properties?
        2. Should the reporting requirement apply only to nanoscale
    material that is ``intentionally produced to have at least one
    dimension that measures between approximately 1 and 100 nanometers,''
    or should it also apply to naturally occurring materials? Why?
        3. Is the meaning of ``intentionally produced'' sufficiently clear?
    If not, in what circumstances would the term be unclear and how might
    it be clarified? Would offering a consultation procedure--by which a
    registrant or applicant describes to EPA the production process that
    results in the presence of a material in the nanoscale size range, and
    EPA responds with a determination regarding whether reporting is
    required--be an acceptable approach to providing clarity?
        4. Should the reporting requirement apply to ingredients in
    pesticides that contain any amount of a nanoscale material, or should
    the requirement apply only if an ingredient contains more than a
    specified percentage (e.g., 10%) of nanoscale material? If the latter,
    what should the specified percentage be and why?
        5. How should the reporting requirement apply to a pesticide
    manufacturer who purchases ingredients that may contain nanoscale
    material?
        6. Are there ways in which the description of ``nanoscale
    materials'' can be refined and clarified, including ways in which
    agglomeration and aggregation could be considered as well as
    suggestions for ways in which more subjective criteria, such as
    ``unique or novel properties'' can be incorporated into the screening
    criteria?
        7. Is EPA's description of ``nanoscale material'' inconsistent with
    other definitions of nanoscale material or similar terms? If so, please
    comment on whether such differences create any regulatory issues. In
    particular, does the focus on ``intentionally produced'' materials
    create any such inconsistency with other definitions of nanoscale
    materials or similar terms?
        8. If a pesticide is identified as containing a particular
    nanoscale material, what would be the most useful next steps to inform
    EPA's understanding of potential risks associated with the pesticide?
    Are there tests that could provide useful information toward an
    understanding of risk that would be common to all nanoscale materials,
    or should the data requirements necessarily be compound- and situation-
    specific? How should bioavailability be considered in determining
    testing requirements (e.g., are nano-particles respirable or bound to
    other components)?
        With respect to the proposed approaches, EPA is seeking comment on
    how to implement them to ensure efficient, effective, and timely review
    of applications. EPA specifically invites comments on the following
    issues:
        1. Is there a way to determine, in advance of receiving an
    application for registration of a product containing a nanoscale
    material, whether a particular kind of nanoscale material has
    properties that, for purposes of risk assessment, are essentially the
    same as larger sized materials of the same substance? If so, how would
    such determinations be made and on what would they be based?
        2. What kinds of information should EPA accept as demonstrating
    that a pesticide product containing a nanoscale ingredient is identical
    or substantially similar to a currently registered pesticide or differs
    only in ways that would not significantly increase the risk of
    unreasonable adverse effects on the environment, and that approving the
    registration in the manner proposed would not significantly increase
    the risk of any unreasonable adverse effect on the environment?
        3. Can you suggest any alternative(s) to the proposed approaches
    that would be equally or even more effective in addressing the status
    of nanoscale materials as new active or inert ingredients for purposes
    of both FIFRA and PRIA, keeping in mind the data showing that size,
    especially when reduced below approximately 100 nm, may alter the
    manner in which materials behave and, in turn, the potential risk to
    human health and the environment associated with such materials?
        With respect to the potential alternative ways of obtaining the
    needed information on what nanoscale materials are in pesticide
    products, EPA specifically invites comments on the following issues:
        1. Has EPA appropriately characterized in this document the current
    scientific understanding of the potential risks of nanoscale materials?
    If not, please comment on how to characterize the potential risks of nanoscale materials. How would the  perception of the risks of nanoscale materials differ depending on the  approach used by EPA to require needed data on nanoscale materials in  pesticides? How could EPA lessen the possibility that issuance of a
    final requirement to report what nanoscale materials are in pesticides
    will result in a public misunderstanding of the potential risks of
    nanotechnology more generally?
        2. Do commenters believe that identification of the nanoscale
    materials in pesticide products is relevant to EPA's statutory
    determination regarding the potential for unreasonable adverse effects
    on the environment? Please provide the scientific or legal basis for
    your view.
        3. Has EPA characterized the alternative approaches with respect to
    which they would: (a) result in a misunderstanding of the potential
    risks posed by nanoscale materials; (b) result in the timely submission
    of needed information; and (c) impose burdens on pesticide companies,
    those whose products do, and do not, contain nanoscale materials? If
    not, please comment on those issues.
        4. If EPA uses FIFRA section 6(a)(2) to obtain the needed
    information on nanoscale materials in pesticides, how could the Agency
    ensure that its action is not mischaracterized or misunderstood as a
    determination that the mere fact that a pesticide contains nanoscale
    materials causes unreasonable adverse environmental effects?
        5. If EPA were to use DCIs to obtain the needed information on
    nanoscale materials in pesticides, how could EPA reduce both the
    burdens on registrants and on EPA, as well as the time required to
    complete such a process? For example, is it possible to reduce the
    burdens on registrants by targeting only certain types of products? If
    so, how would EPA determine which products should receive DCIs?
        6. What are the advantages and disadvantages of requesting
    information on nanoscale materials specifically versus requesting
    information on size distribution generally? (Note that either type of
    information could be collected under either the 6(a)(2) or the
    3(c)(2)(B) approach, except that 6(a)(2) cannot be used to require the
    production of new information that does not already exist, while a
    collection under 3(c)(2)(B) must be directed to an individual
    registrant and requires a response.) Is identifying what nanoscale
    materials are in products a useful first step, or should EPA move
    towards immediate collection of more specific information, such as
    particle size distribution, on products that might contain nanoscale
    materials? Are there other physical and/or chemical properties that
    might be equally or more important for assessing the potential of a
    pesticide to cause unreasonable adverse effects on the environment
    (e.g., morphology, including shape and crystal structure; surface
    chemistry and reactivity; specific surface area, charge; solubility;
    conductive, magnetic, and optical properties)? Should information on
    these properties be separately requested? What would be the value and
    burden of obtaining such information?
        1. If EPA were to use rulemaking to establish data requirements for
    pesticides containing nanoscale materials, what types of information
    should EPA use to determine appropriate data requirements? What types
    of studies should EPA require to evaluate a nanoscale material?
        2. When choosing an approach for obtaining needed data, how should
    EPA weigh considerations relating to the need to update its safety
    evaluations of currently marketed pesticides in a timely manner, the
    goal of ensuring marketplace equity, and the interest in minimizing the
    burdens on regulated entities?

     

    Comments need to be filed by July 18, 2011, either in an e-format via www.regulations.gov or delivered in paper to

    Mail: Office of Pesticide Programs (OPP) Regulatory Public
    Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
    Ave., NW., Washington, DC 20460-0001.
        Delivery: OPP Regulatory Public Docket (7502P),
    Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
    Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
    accepted during the Docket Facility's normal hours of operation (8:30
    a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
    Special arrangements should be made for deliveries of boxed
    information. The Docket Facility telephone number is (703) 305-5805.
       

    Further information on submitting comments may be found at the head of the notice. A docket - EPA-HQ-OPP-2010-0197 - has been established on the Regulations.gov site. A few comments have been filed and may be viewed there, along with supporting and related materials used by EPA in drafting this notice. Members of the Nanotech community are encouragef to file appropriate comments by the July 18, 2011 deadline. Following receipt and review of comments filed by the July 18, 2011 deadline, EPA will publish another notice summarizing the comments.

    The Nano-Knight

    As part of Queen Elizabeth II's Official Birthday, Buckingham Palace released the Queen's Birthday Honours List. Among those honored with a knighthood was Professor Mark Edward Welland of the University of Cambridge, where he heads the Nanoscience Centre and also currently serves as Chief Scientific Advisor to the UK Ministry of Defence. Professor Welland is also the former editor of Nanotechnology, published by the Institute of Physics.

    Professor Welland's knighthood is in recognition of a distinguised career in science and teaching. The rank is that of a Knight Bachelor, which has nothing to do with his marital status, but instead indicates that he is not a member of one of the Chivalric Orders, such as the Order of the British Emprire or the Order of the Garter.

    OECD Issues Guide to Current Developments on the safety of Manufactured Nanomaterials

    As a follow-up to and outgrowth of the June 2005 OECD Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides, and Biotechnology, the OECD Working Party on Manufactured Nanomaterials (WPMN) was established in September 2006, with the mission of helping "member countries efficently address the safety challenges of nanomaterial".

    Presented at the WPMN's March 2011 meeting, "Current Developments/Activities on the Safety of Manufactured Nanomaterials" ". . .is intended to provide delegations and other stakeholders with a "snapshot" of information on activities related to manufactured nanomaterials, as well as other activities . . . at the national and international level".

    The "snapshot" consists of two sections; section I, "Recent and Planned National Activities in Chemical Regulatory Area on Health and Environmental Safety Aspects of Manufactured Nanomaterials" and section II, "Current Activities in Other Organisations Related to Nanotechnologies/Nanomaterials". Section I is the larger of the two sections, focusing on the written reports that members of the OECD submitted to the WPMN. From the length and depth of these reports, it is easy to gauge which nations are actively involved in nanomaterials research, development and can be judged to have a fairly well developed nanoindustrial segment to their national economies. Australia, for example, submitted a five and a half page report discussing what the government and regulatory agencies have done and plan to do in the future to insure that facilities manufacturing nanomaterials reduce the levels of worker exposure, possible impact on the environment, etc, while Belgium's report, in contrast, consisted of four paragraphs.

    Section II is far shorter, totaling four pages, focused on the activities of the International Organisation for Standardisation Technical Committee-Nanotechnologies (ISO/TC 229), the World Health Organisation (WHO) and the Food and Agriculture Organisation of the UN (FAO).

    The value of the "snapshot" is that it provides stakeholders, both in the respective nations and internationally, with useful information regarding various nations support of their nanoindustries and how current and future regulation affecting workers, the environment and the general public's exposure to nanomaterials might impact on established and emerging nanoindustries.